Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 Jul;68(7):4700-4.
doi: 10.1128/JVI.68.7.4700-4704.1994.

Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice

Affiliations

Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice

M Battegay et al. J Virol. 1994 Jul.

Abstract

CD4+ T cells play an important role in regulating the immune response; their contribution to virus clearance is variable. Mice that lack CD4+ T cells (CD4-/- mice) and are therefore unable to produce neutralizing antibodies cleared viscero-lymphotropic lymphocytic choriomeningitis virus (LCMV) strain WE when infected intravenously with a low dose (2 x 10(2) PFU) because of an effective CD8+ cytotoxic T-cell (CTL) response. In contrast, infection with a high dose (2 x 10(6) PFU) of LCMV strain WE led to expansion of antiviral CTL, which disappeared in CD4-/- mice; in contrast, CD4+ T-cell-competent mice developed antiviral memory CTL. This exhaustion of specific CTL caused viral persistence in CD4-/- mice, whereas CD4+ T-cell-competent mice eliminated the virus. After infection of CD4-/- mice with the faster-replicating LCMV strain DOCILE, abrogation of CTL response and establishment of viral persistence developed after infection with a low dose (5 x 10(2) PFU), i.e., an about 100-fold lower dose than in CD(4+)-competent control mice. These results show that absence of T help enhances establishment of an LCMV carrier state in selected situations.

PubMed Disclaimer

References

    1. Transplant Rev. 1974;19(0):56-88 - PubMed
    1. Int Immunol. 1993 Oct;5(10):1193-8 - PubMed
    1. J Immunol. 1976 Nov;117(5 Pt 1):1495-502 - PubMed
    1. J Exp Med. 1977 May 1;145(5):1131-43 - PubMed
    1. Nature. 1978 Dec 21-28;276(5690):829-31 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources